- Investing Ideas
- /
- Global Potentially Undervalued Companies
Global Potentially Undervalued Companies
Results
35346
0 new
Companies with a Value score of at least 3, ordered by Value score
35,346 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
6929 | HK$3.83 | -24.5% | n/a | HK$3.2b | HK$9.06 | PE10.6x | E7.6% | n/a | Healthcare | ||
NTR | €0.93 | 0.5% | 11.6% | €209.9m | €1.13 | PS8.2x | E67.3% | n/a | Pharmaceuticals & Biotech | ||
SIA | €136.72 | 1.3% | 32.2% | €106.4b | €180.58 | PE11.8x | E1.2% | 3.2% | Capital Goods | ||
CRR | €17.28 | 1.5% | 6.3% | €12.6b | €21.14 | PE12.2x | E6.7% | 3.0% | Consumer Retailing | ||
506 | HK$2.84 | -0.4% | 15.0% | HK$7.8b | HK$3.90 | PE9.4x | E5.9% | 4.5% | Food, Beverage & Tobacco | ||
CARDL | UK£0.80 | -3.5% | -29.1% | UK£279.7m | UK£1.66 | PE6.9x | E15.6% | 3.0% | Retail | ||
HALO | US$42.57 | -30.3% | 6.4% | US$5.8b | US$62.44 | PE13.8x | E21.1% | n/a | Pharmaceuticals & Biotech | ||
TTFN.F | US$62.20 | 2.5% | -10.3% | US$132.5b | US$77.43 | PE8.3x | E0.1% | 5.4% | Energy | ||
SAN | €4.59 | 1.8% | 22.5% | €70.4b | €5.68 | PB0.7x | E-0.3% | 4.3% | Banks | ||
0IX0 | €16.70 | -6.4% | -9.1% | €490.3m | €25.49 | PE7.3x | E5.5% | 4.2% | Commercial Services | ||
EMG | UK£2.10 | 2.3% | -3.7% | UK£2.4b | UK£2.71 | PE9.7x | E15.0% | 6.1% | Diversified Financials | ||
C2H | €95.50 | 6.7% | 11.7% | €4.3b | €137.11 | PE6.4x | E6.1% | 6.3% | Transportation | ||
MUX | €21.55 | -6.9% | -29.0% | €467.6m | €43.00 | PS0.09x | E-45.5% | 10.3% | Diversified Financials | ||
CIVI | US$51.99 | -0.4% | -25.1% | US$4.9b | US$74.53 | PE5.1x | E-3.3% | 9.6% | Energy | ||
RBBN | US$3.83 | -10.1% | 81.5% | US$682.2m | US$5.80 | PS0.8x | S5.7% | n/a | Tech | ||
0MN5 | €36.55 | 2.4% | -2.4% | €347.5m | €44.27 | PE17.3x | E18.8% | 4.6% | Software | ||
HDBK | ج.م52.87 | -0.2% | 32.3% | ج.م28.1b | ج.م65.81 | PB1.3x | E-1.4% | 5.7% | Banks | ||
0QCO | €0.72 | -2.9% | -33.4% | €484.0m | €1.81 | PS1.8x | E73.2% | n/a | Pharmaceuticals & Biotech | ||
CVE | US$15.98 | -0.3% | -12.0% | US$40.3b | US$22.41 | PE11.1x | E5.0% | 3.6% | Energy | ||
HAFN | US$5.39 | 0.9% | -21.3% | US$30.5b | US$8.94 | PE3.4x | E-20.2% | 18.7% | Energy | ||
OSB | UK£3.80 | 0.05% | 1.8% | UK£1.4b | UK£5.49 | PE3.7x | E-3.8% | 8.6% | Diversified Financials | ||
NSP | €0.70 | -7.6% | -60.4% | €14.6m | €1.29 | PS0.5x | E80.5% | n/a | Software | ||
SNR | UK£1.48 | 0% | -10.5% | UK£602.7m | UK£1.92 | PE19.8x | E31.5% | 1.7% | Capital Goods | ||
0YT | €3.52 | -1.1% | 10.7% | €498.2m | €5.62 | PE4.7x | E-7.9% | 2.8% | Energy |